GlobeNewswire Inc | May 27, 2021 08:30AM EDT

May 27, 2021

WARREN, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (Bellerophon or the Company), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced thatFabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference, being held June 1-4, 2021.

Presentation Details

Date: Thursday, June 3, 2021Time: 3:00 PM Eastern Time

A live audio webcast and replay of the presentation will be available in the Investors section on the Companys website at www.bellerophon.com.

About BellerophonBellerophon Therapeuticsis a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulseprogram, a proprietary pulsatile nitric oxide delivery system. For more information, please visitwww.bellerophon.com.

ContactsLifeSci Advisors:Brian Ritchie(212) 915-2578britchie@lifesciadvisors.com